Publications by authors named "Uwe Karsten"

Claim this Profile
I
Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.
Sabine Heublein, Doris Mayr, Markus Egger, Uwe Karsten, Steffen Goletz

J Exp Clin Cancer Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What makes cancer stem cell markers different?
Uwe Karsten, Steffen Goletz

Springerplus· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentric and multifocal versus unifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology.
Tobias Weissenbacher, Eva Hirte, Christina Kuhn, Wolfgang Janni, Doris Mayr, Uwe Karsten

BMC Cancer· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6.
Philippe Ulsemer, Gemma Henderson, Kawe Toutounian, Anja Löffler, Jens Schmidt, Uwe Karsten

Cancer Immunol Immunother· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staining of MUC1 in ovarian cancer tissues with PankoMab-GEX detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8.
Darius Dian, Miriam Lenhard, Doris Mayr, Sabine Heublein, Uwe Karsten

Histol Histopathol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of MUC1 in sera of ovarian cancer patients and in sera of patients with benign changes of the ovaries with CA15-3, CA27.29, and PankoMab.
Udo Jeschke, Irmi Wiest, Anamur Lan Schumacher, Markus Kupka, Brigitte Rack, Uwe Karsten

Anticancer Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety assessment of the commensal strain Bacteroides xylanisolvens DSM 23964.
Philippe Ulsemer, Kawe Toutounian, Jens Schmidt, Jost Leuschner, Uwe Karsten

Regul Toxicol Pharmacol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary safety evaluation of a new Bacteroides xylanisolvens isolate.
Philippe Ulsemer, Kawe Toutounian, Jens Schmidt, Uwe Karsten, Steffen Goletz

Appl Environ Microbiol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence of the human tumor-specific antigen structure Galβ1-3GalNAcα- (Thomsen-Friedenreich) and related structures on gut bacteria: prevalence, immunochemical analysis and structural confirmation.
Gemma Henderson, Philippe Ulsemer, Ute Schöber, Anja Löffler, Carl-Alfred Alpert, Uwe Karsten

Glycobiology· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells.
Wei-Ming Lin, Uwe Karsten, Steffen Goletz, Ruo-Chuan Cheng, Yi Cao

Int J Exp Pathol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactivity of a humanized antibody (hPankoMab) towards a tumor-related MUC1 epitope (TA-MUC1) with various human carcinomas.
Xiao-Na Fan, Uwe Karsten, Steffen Goletz, Yi Cao

Pathol Res Pract· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-expression of CD173 (H2) and CD174 (Lewis Y) with CD44 suggests that fucosylated histo-blood group antigens are markers of breast cancer-initiating cells.
Wei-Ming Lin, Uwe Karsten, Steffen Goletz, Ruo-Chuan Cheng, Yi Cao

Virchows Arch· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The human endometrium expresses the glycoprotein mucin-1 and shows positive correlation for Thomsen-Friedenreich epitope expression and galectin-1 binding.
Udo Jeschke, Hermann Walzel, Ioannis Mylonas, Panos Papadopoulos, Naim Shabani, Uwe Karsten

J Histochem Cytochem· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies.
Darius Dian, Wolfgang Janni, Christina Kuhn, Doris Mayr, Uwe Karsten

Onkologie· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
Christian Schindlbeck, Julia Stellwagen, Udo Jeschke, Uwe Karsten, Brigitte Rack

Clin Exp Metastasis· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of CD175 (Tn), CD175s (sialosyl-Tn) and CD176 (Thomsen-Friedenreich antigen) on malignant human hematopoietic cells.
Yi Cao, Anette Merling, Uwe Karsten, Steffen Goletz, Michael Punzel

Int J Cancer· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Thomsen-Friedenreich disaccharide as antigen for in vivo tumor targeting with multivalent scFvs.
Peter Ravn, Renate Stahn, Antje Danielczyk, Dorian Faulstich, Uwe Karsten

Cancer Immunol Immunother· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
Christian Schindlbeck, Udo Jeschke, Sandra Schulze, Uwe Karsten, Wolfgang Janni

Breast Cancer Res Treat· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PankoMab: a potent new generation anti-tumour MUC1 antibody.
Antje Danielczyk, Renate Stahn, Dorian Faulstich, Anja Löffler, Angela Märten, Uwe Karsten

Cancer Immunol Immunother· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Binding of galectin-1 (gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody.
Udo Jeschke, Uwe Karsten, Irmi Wiest, Sandra Schulze, Christina Kuhn

Histochem Cell Biol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection, isolation and partial characterization of an immunostimulating glycoprotein from Rhodococcus fascians.
Günter Butschak, Uwe Karsten, Ute Schelhaas, Holger Ott, Andreas Emmendörffer

Int Immunopharmacol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulation of hCG protein and mRNA in first trimester villous cytotrophoblast cells in vitro by glycodelin A.
Udo Jeschke, Uwe Karsten, Toralf Reimer, Dagmar-Ulrike Richter, Claudia Bergemann

J Perinat Med· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What makes MUC1 a tumor antigen?
Uwe Karsten, Silvia von Mensdorff-Pouilly, Steffen Goletz

Tumour Biol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors.
Udo Jeschke, Anja Bischof, Runa Speer, Volker Briese, Dagmar-Ulrike Richter, Uwe Karsten

Anticancer Res· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.
Christian Schindlbeck, Udo Jeschke, Sandra Schulze, Uwe Karsten, Wolfgang Janni

Histochem Cell Biol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis